Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Imatinib mesylate:MCnc:Pt:Ser/Plas:Qn

Known as: Imatinib mésylate [Masse/Volume] Sérum/Plasma ; Numérique, Imatinib mesylate:Mass Concentration:Point in time:Serum/Plasma:Quantitative, Imatinib mesylate [Mass/volume] in Serum or Plasma 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The anticancer drug imatinib is an inhibitor of the platelet-derived growth factor receptor (PDGFR) kinases, which are involved… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 4
Is this relevant?
2010
2010
L’Imatinib mesilato e un inibitore delle tirosin chinasi, utilizzato nel trattamento della leucemia mieloide cronica, dei tumori… Expand
  • figure 1
  • figure 2
Is this relevant?
2008
2008
Cette invention se rapporte a une dispersion solide de mesylate d'imatinib comprenant du mesylate d'imatinib et un porteur… Expand
Is this relevant?
2007
2007
L’imatinib mesylate (IM) a profondement modifie les principes de traitement et de surveillance de la leucemie myeloide chronique… Expand
Is this relevant?
2004
2004
Notre presentation a pour but d’exposer les modifications morphologiques post therapeutiques d’une tumeur stromale gastro… Expand
Is this relevant?
2003
2003
667 M/S n° 6-7, vol. 19, juin-juillet 2003 > La leucémie myéloïde chronique (LMC) est une affection maligne clonale de la cellule… Expand
Is this relevant?
2002
2002
Le dernier congres de l'American Society of Clinical Oncology a Orlando a conforte la place des therapeutiques ciblees du cancer… Expand
Is this relevant?
1991
1991
Hemos investigado la utilidad de una nueva sustancia anti-proteasa, el gabexato-mesilato (FOY) en el tratamiento de la… Expand
Is this relevant?